Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Grant or award Director acquired 3,861 shares (grant or award)
  2. 4 Grant or award Director acquired 15,444 shares (grant or award)
  3. 4 Grant or award Director acquired 15,444 shares (grant or award)
  4. 8-K Event Executive or director change · Shareholder vote results
  5. 4 Open-market buy Director bought 67,541 shares at an average $3.90 ($263,208)
  6. 4 Open-market buy Director bought 85,900 shares at an average $3.15 ($270,477)
  7. 4 Open-market buy President and CEO bought 10,000 shares at $3.05 ($30,530)
  8. 4 Open-market buy Director bought 115,292 shares at an average $2.90 ($333,777)
  9. CT ORDER Other Confidential Order
  10. ARS Other Annual Report to Security Holders
  11. 10-Q Report Quarterly Report
  12. DEF 14A Proxy Proxy Statement
  13. 10-K Report Annual Report
  14. 4 Grant or award VP, IP and Legal, Gen. Counsel acquired 5,284 shares (grant or award)
  15. 4 Grant or award VP, Fin. and Admin., CFO acquired 5,284 shares (grant or award)
  16. 4 Grant or award SVP, Chief Medical Officer acquired 7,477 shares (grant or award)
  17. 4 Grant or award Sr. VP, Drug Development acquired 8,224 shares (grant or award)
  18. 4 Grant or award Sr. VP, Pgm Mgmt and Clin Ops acquired 7,908 shares (grant or award)
  19. 4 Grant or award Sr. VP, Chief Comm. Officer acquired 8,627 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 13,839 shares (grant or award)

Page 52 of 62 · 1,224 filings